Researchers conduct largest clinical trial seeking to prevent heart failure among childhood cancer survivors

Physicians at City of Hope in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure. The findings published in The Lancet Oncology show that the blood vessel relaxing medication carvedilol is safe for childhood cancer survivors to take and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart